In our present IHC study of NAFLD patients, we detected significantly higher RIG1, IRF3, pNRF2, and SOCS3 protein expressions in NASH patients compared with NAFL patients. This evidence concerns the gene SOCS3 and metabolic dysfunction-associated steatotic liver disease.